ICD-10 Transition Training and Consulting – Speaking from Experience

ICD-10 assessments should start with a thorough understanding of how to communicate, educate, train at all levels.  Here are some topics our team can speak to for your organization.

  • ICD-10 Organization Strategy
  • ICD-10 and Business Continuity Planning presentation at panel at the Workgroup for Electronic Data Interchange (WEDI) 5010 ICD-10 Forum. Reston VA ( July 20, 2011)
  • ICD-10 Translation and GEM
  • ICD-10 Clinical Documentation
  • ICD-10 Code Definition and Code Structure
  • ICD-10 Medical Management
  • Redefining Policies, Rules and Categories in ICD-10
  • ICD-10 Mapping Strategy and Resulting Clinical Issues
  • The ICD-10 Transition; Challenges and Opportunities
  • The Spectre of ICD-10 – Healthcare IT National Meeting
  • ICD-10, Peeling the Onion online webinar presentation.
  • ICD – 10 Implementation: What does it mean to your organization and are you prepared for it?
  • Preparing for ICD-10 Code Definition and Code Structure
  • ICD-10 The Orthopedic Perspective
  • ICD-10 Peeling the Layers
  • ICD-10 Physician Impacts
  • How to tackle ICD-10 and Healthcare Reform – Best practices for overcoming healthcare’s biggest hurdles
  • ICD-10, Peeling the Onion and ICD-10 Business Impacts
  • ICD-10 Will You Be Ready
  • ICD-10 Crosswalk Primer
  • ICD-10CM: Moving to Better Definitions of the Patients Health State
  • Lifecycle of a Code
  • Translation Accountability
  • Clinical Policy Remediation – Redefining the policy intent in ICD-10
  • Clinical Perspective on ICD-10 Translation
  • ICD-10 – The clinician perspective
  • ICD-10 – An external perspective
  • Meeting HIPAA5010 and ICD-10 compliance Challenges
  • Appropriate Use of Mapping and Crosswalks in Transitioning to ICD-10
  • The Clinical Impact of ICD-10: The “Life Cycle” of the Creation and Use of Codes
  • ICD-10CM: A Coding Model that Better Defines the Patient’s Health State
  • Implementing ICD-10: Letting Your Business and Clinical Teams Lead the Way
  • ICD-10CM: Potentials for loss of data integrity with crosswalks
  • Sitting in the Hot Seat: Overcoming the Risk of Fraud with ICD-10 Adoption
  • The Impact of the ICD-10 Transition
  • ICD-10: Clinical Consideration
  • ICD-10CM: A Coding Model that Better Defines the Patient’s Health Stat
  • ICD-10 The Impact of Change
  • Related Posts:


Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See https://www.noworldborders.com/news/ and https://www.noworldborders.com/clients/ for more about the company.

Leave a Reply